To access the full text documents, please follow this link: http://hdl.handle.net/2445/105539
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Arimany Nardi, Cristina |
dc.contributor.author | Minuesa, Gerard |
dc.contributor.author | Keller, Thorsten |
dc.contributor.author | Erkizia, Itziar |
dc.contributor.author | Koepsell, Hermann |
dc.contributor.author | Martínez-Picado, Javier |
dc.contributor.author | Pastor Anglada, Marçal |
dc.date | 2017-01-12T16:11:35Z |
dc.date | 2017-01-12T16:11:35Z |
dc.date | 2016-06-24 |
dc.date | 2017-01-12T16:11:35Z |
dc.identifier.citation | 1663-9812 |
dc.identifier.citation | 663314 |
dc.identifier.uri | http://hdl.handle.net/2445/105539 |
dc.format | 10 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation | Reproducció del document publicat a: https://doi.org/10.3389/fphar.2016.00175 |
dc.relation | Frontiers in Pharmacology, 2016, vol. 7, p. 175 |
dc.relation | https://doi.org/10.3389/fphar.2016.00175 |
dc.rights | cc-by (c) Arimany Nardi, Cristina et al., 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Farmacogenètica |
dc.subject | Malalties infeccioses |
dc.subject | VIH (Virus) |
dc.subject | Terapèutica |
dc.subject | Pharmacogenetics |
dc.subject | Communicable diseases |
dc.subject | HIV (Viruses) |
dc.subject | Therapeutics |
dc.title | Role of human Organic Cation Transporter 1 (hOCT1) polymorphisms in lamivudine (3TC) uptake and drug-drug interactions. |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |